136 related articles for article (PubMed ID: 37419729)
1. [Environmental and occupational risk factors for myelodysplastic syndrome].
Garnier R
Bull Cancer; 2023 Nov; 110(11):1116-1128. PubMed ID: 37419729
[TBL] [Abstract][Full Text] [Related]
2. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.
Schnatter AR; Glass DC; Tang G; Irons RD; Rushton L
J Natl Cancer Inst; 2012 Nov; 104(22):1724-37. PubMed ID: 23111193
[TBL] [Abstract][Full Text] [Related]
4. Benzene risk assessment: does new evidence on myelodysplastic syndrome justify a new approach?
Li W; Schnatter AR
Crit Rev Toxicol; 2018 Jul; 48(6):417-432. PubMed ID: 29745826
[TBL] [Abstract][Full Text] [Related]
5. The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens.
Mundt KA; Dell LD; Boffetta P; Beckett EM; Lynch HN; Desai VJ; Lin CK; Thompson WJ
BMC Cancer; 2021 Mar; 21(1):227. PubMed ID: 33676443
[TBL] [Abstract][Full Text] [Related]
6. Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece.
Avgerinou C; Giannezi I; Theodoropoulou S; Lazaris V; Kolliopoulou G; Zikos P; Alamanos Y; Leotsinidis M; Symeonidis A
Hematology; 2017 Aug; 22(7):419-429. PubMed ID: 28102107
[TBL] [Abstract][Full Text] [Related]
7. Benzene Exposure Response and Risk of Myeloid Neoplasms in Chinese Workers: A Multicenter Case-Cohort Study.
Linet MS; Gilbert ES; Vermeulen R; Dores GM; Yin SN; Portengen L; Hayes RB; Ji BT; Lan Q; Li GL; Rothman N;
J Natl Cancer Inst; 2019 May; 111(5):465-474. PubMed ID: 30520970
[TBL] [Abstract][Full Text] [Related]
8. Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study.
Nisse C; Lorthois C; Dorp V; Eloy E; Haguenoer JM; Fenaux P
Leukemia; 1995 Apr; 9(4):693-9. PubMed ID: 7723405
[TBL] [Abstract][Full Text] [Related]
9. Hospital-Based Case-Control Study of MDS Subtypes and Benzene Exposure in Shanghai.
Copley GB; Schnatter AR; Armstrong TW; Irons RD; Chen M; Wang XQ; Kerzic P
J Occup Environ Med; 2017 Apr; 59(4):349-355. PubMed ID: 28146040
[TBL] [Abstract][Full Text] [Related]
10. Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population.
Lv L; Lin G; Gao X; Wu C; Dai J; Yang Y; Zou H; Sun H; Gu M; Chen X; Fu H; Bao L
Am J Hematol; 2011 Feb; 86(2):163-9. PubMed ID: 21264898
[TBL] [Abstract][Full Text] [Related]
11. Occupational and environmental etiology of MDS.
Bowen DT
Best Pract Res Clin Haematol; 2013 Dec; 26(4):319-26. PubMed ID: 24507809
[TBL] [Abstract][Full Text] [Related]
12. Integrating WHO 2001-2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure.
Irons RD; Gross SA; Le A; Wang XQ; Chen Y; Ryder J; Schnatter AR
Chem Biol Interact; 2010 Mar; 184(1-2):30-8. PubMed ID: 19941839
[TBL] [Abstract][Full Text] [Related]
13. Pesticide exposure as a risk factor for myelodysplastic syndromes: a meta-analysis based on 1,942 cases and 5,359 controls.
Jin J; Yu M; Hu C; Ye L; Xie L; Jin J; Chen F; Tong H
PLoS One; 2014; 9(10):e110850. PubMed ID: 25335083
[TBL] [Abstract][Full Text] [Related]
14. Benzene exposure and refractory sideroblastic erythropoiesis: is there an association?
Natelson EA
Am J Med Sci; 2007 Nov; 334(5):356-60. PubMed ID: 18004090
[TBL] [Abstract][Full Text] [Related]
15. Environmental and occupational determinants of myelodysplastic syndrome: A case-control study from Pakistan.
Anwar N; Arshad A; Fatima N; Shaheen S; Bukhari S; Shamsi T
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1580. PubMed ID: 34708590
[TBL] [Abstract][Full Text] [Related]
16. Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease.
Goldberg H; Lusk E; Moore J; Nowell PC; Besa EC
Cancer Res; 1990 Nov; 50(21):6876-81. PubMed ID: 2208156
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
Yarosh R; Roesler MA; Murray T; Cioc A; Hirsch B; Nguyen P; Warlick E; Poynter JN
Cancer Causes Control; 2021 Mar; 32(3):241-250. PubMed ID: 33392905
[TBL] [Abstract][Full Text] [Related]
18. Benzene, the exposome and future investigations of leukemia etiology.
Smith MT; Zhang L; McHale CM; Skibola CF; Rappaport SM
Chem Biol Interact; 2011 Jun; 192(1-2):155-9. PubMed ID: 21333640
[TBL] [Abstract][Full Text] [Related]
19. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings.
Rigolin GM; Cuneo A; Roberti MG; Bardi A; Bigoni R; Piva N; Minotto C; Agostini P; De Angeli C; Del Senno L; Spanedda R; Castoldi G
Br J Haematol; 1998 Oct; 103(1):189-97. PubMed ID: 9792307
[TBL] [Abstract][Full Text] [Related]
20. Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France.
Nisse C; Haguenoer JM; Grandbastien B; Preudhomme C; Fontaine B; Brillet JM; Lejeune R; Fenaux P
Br J Haematol; 2001 Mar; 112(4):927-35. PubMed ID: 11298587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
